• Request information
  • EN
    • DE
    • FR
  • 0049 (0)4561 – 51325-00
  • [email protected]
  • Linkedin
  • Suche
Logo GYNEMED GmbH & Co. KG -
  • Our company
    • GYNEMED
      • Contact
    • Hamilton Thorne Group
      • Hamilton Thorne Inc.
      • Planer
      • IVFtech
      • Tek-Event
      • MICROPTIC S.L.
  • Products
    • GYNEMED
    • Cell culture media
    • Laboratory Equipment
    • Consumables
    • Diagnostics
    • Partner
      • Hamilton Thorne Inc.
      • Microptic
      • Planer
      • IVFtech
      • Astec
      • Narishige
      • IMT International
      • Gynetics
      • Microtech
      • MFC Global
      • Birr
      • Tristel
      • Bridea
  • News & Congresses
    • News
    • Congresses and Symposia
  • Distributors
    • Europe
    • Asia
    • Africa
    • America
    • Australia
  • Certificate of Analysis
  • Documentation
    • Zertifikate
      • EN ISO 13485:2016
    • Instruction for use
      • MediaLine
      • Gynemed Micropipettes
    • MSDS
    • Broschures
    • Consent according to data protection
NewsNewsCCM-iBIS Time-Lapse-System from Gynemed

CCM-iBIS Time-Lapse-System from Gynemed

https://gynemed.de/wp-content/uploads/2020/06/VIDEO-2020-06-08-11-34-37.mp4
Ask for an offer …

 

Details

Published on

June 8, 2020

Published in

  • News

Share

All Posts Certification audit by MedCert GmbH ESHRE virtual 36th Annual Meeting
  • Imprint
  • Linkedin
  • General Terms and Agreements
  • Privacy Policy
  • © GYNEMED GmbH & Co. KG
  • A Hamilton Thorne Company

Big News: We’re Growing!

Nexpring Health has completed the acquisition of Irvine Scientific’s ART and Cytogenetics

product lines, uniting media, consumables, capital equipment, and lab services under one trusted brand.

✅ Same trusted quality and support
✅ More connected solutions for your entire IVF workflow
✅ No disruption to your current ordering or service

We’re excited to bring even more value to embryologists, clinicians, and fertility clinics, because you’re at the center of everything we do.

Learn More About the Acquisition